#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Medical News

farmakokinetický protokol krev zkumavky

Practical Two-Point Pharmacokinetic Protocol in Hemophilia A

31. 1. 2022 Source: Hemophilia

A recently published study confirmed the practicality of a shortened and simple pharmacokinetic protocol for patients with hemophilia A.

tablety ilu

Memantine in Dementia Therapy –⁠ Current Findings and Possible Future Applications

Memantine is an inhibitor of NMDA receptors, which are pathologically activated by excessive concentrations of glutamate in the synaptic cleft in Alzheimer's disease. It is indicated in the treatment…
26. 1. 2022 Source: Cognitive in the treatment of Alzheimer's disease
operace_krev

Administration of aPCC as a Prevention of Bleeding After Major Cardiac Surgical Procedures

The possibility of actively preventing severe bleeding after a major cardiac surgical procedure using cardiopulmonary bypass (CPB) by administering a concentrate of activated procoagulant complex…
22. 11. 2021 Source: Hemophilia
kapka krve_ruce

Neutralizing Antibodies Against Emicizumab –⁠ Detailed Analysis Based on a Case Study

Japanese authors investigated the mechanism of reduced efficacy of emicizumab in an adult patient with hemophilia A and an inhibitor, whose treatment was discontinued due to repeated bleeding…
22. 11. 2021 Source: Hemophilia
krvaceni_tepna_zila_krev

Cost-Effectiveness of Preparations Used to Stop Bleeding in Patients with AHA

Choosing the right preparation to manage acute bleeding in patients with acquired hemophilia A is not always simple. An interesting perspective and recommendations are provided by a model analysis…
1. 11. 2021 Source: Hemophilia

Risk of Developing Inhibitors in People with Milder Forms of Hemophilia

Moderate and mild hemophilia A differ from the severe form not only in clinical course and bleeding risk, but also in the risk of developing neutralizing antibodies (inhibitors).
1. 11. 2021 Source: Hemophilia
hemofilie_zkumavky

Individualized Prophylaxis with Achieving Higher Minimum Levels as a Possible Path to Optimal Treatment of Hemophilia A

Prophylactic administration of factor VIII (FVIII) concentrate is the standard of care for individuals with severe hemophilia A. Traditionally, the goal of prophylaxis has been to maintain minimum…
15. 9. 2021 Source: Hemophilia
Metamizol analgetika

Metamizole at a Glance and in Practice –⁠ Effective Non-Opioid Analgesic for All Ages

The regular webinar of the General Medicine Society of ČLS JEP this spring, besides addressing the current coronavirus situation, also focused on the issue and treatment of pain in its specialized…
15. 9. 2021 Source: Analgesia
klouby , vyšetření

Monitoring of Joint Health is an Important Part of Hemophilia Care

Joint health has become a key aspect of the quality of life for people with hemophilia. The possibilities of monitoring early joint damage in hemophiliacs were evaluated in a recently published…
18. 8. 2021 Source: Hemophilia
 :IMPORT-SZ:

Metamizole in the Treatment of Acute Postoperative Pain

In many countries, metamizole is considered a first-choice non-opioid analgesic. The analysis presented below, published in the Cochrane Database of Systematic Reviews, examined the efficacy and…
25. 5. 2021 Source: Analgesia
1 2 3 4 5
Filter by speciality
Remove filters

Popular this week
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#